Arena Pharmaceuticals, Inc. Assets, Fair Value Disclosure
Arena Pharmaceuticals, Inc. had Assets, Fair Value Disclosure of $656.86 million as of 2021-12-31, per its 10-K filed 2022-02-23.
Discontinued › Notes › Fair Value Disclosures
us-gaap:AssetsFairValueDisclosure · last filed 2022-02-23
- 2021-12-31: Assets, Fair Value Disclosure $656.86M.
- 2021-09-30: Assets, Fair Value Disclosure $752.31M.
- 2021-06-30: Assets, Fair Value Disclosure $934.66M.
- 2021-03-31: Assets, Fair Value Disclosure $994.51M.
| Period end | Assets, Fair Value Disclosure |
|---|---|
| 2021-12-31 | $656.86M 10-K · filed 2022-02-23 |
| 2021-09-30 | $752.31M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $934.66M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $994.51M 10-Q · filed 2021-05-05 |
| 2020-12-31 | $980.19M 10-K · filed 2022-02-23 |
| 2020-03-31 | $980.19M 10-Q · filed 2021-05-05 |